US awards $1.6 billion to Novavax firm for COVID-19 vaccine development
Under the terms of its agreement with the Department of Health and Human Services (HHS) and Department of Defense, Novavax agrees to deliver 100 million doses of its vaccine, potentially by the end of the year.











